Showing 7301-7310 of 10620 results for "".
- AI Innovations Reshape Radiology: Breast Cancer and MRI Breakthroughshttps://reachmd.com/news/ai-innovations-reshape-radiology-breast-cancer-and-mri-breakthroughs/2475402/Radiologists seeking to close diagnostic blind spots in both breast cancer detection and MRI scans are increasingly leveraging AI diagnostic tools, as recent findings from AI for breast cancer detection reveal its capacity to detect and local
- Evolving Strategies in ACL Reconstruction: New Grafts and Rehabilitation Insights for Improved Outcomeshttps://reachmd.com/news/evolving-strategies-in-acl-reconstruction-new-grafts-and-rehabilitation-insights-for-improved-outcomes/2475325/As orthopedic surgeons confront persistent challenges in restoring knee stability, recent research by Janne Spierings on bare ACL graft protocols offers promising insights into anterior cruciate ligament reconstruction outcomes. Persis
- Advancing Breast Cancer Awareness and Detection: Educational Imperatives for Health Sciencehttps://reachmd.com/news/advancing-breast-cancer-awareness-and-detection-educational-imperatives-for-health-science/2475331/Breast cancer is a leading cause of cancer-related mortality among women worldwide, yet tomorrow’s clinicians a
- AI-Based Imaging Innovations Set New Standards in Neurosurgeryhttps://reachmd.com/news/ai-based-imaging-innovations-set-new-standards-in-neurosurgery/2475305/Advanced imaging technologies—especially AI-based brain mapping tools and novel tumor probes—are reshaping neurosurgery by enhancing surgical precision, safety, and real-time decision-making. Neurosurgeons have long faced the challenge
- Microhematuria Guidelines: 2025 Updates Demand Practice Modernizationhttps://reachmd.com/news/microhematuria-guidelines-2025-updates-demand-practice-modernization/2475306/Urologists are contending with legacy assessment pathways for microhematuria, and the microhematuria 2025 updates underscore an urgent need to modernize practice to avert diagnostic delays and unnecessary interventions. <
- Emerging Approaches in Glaucoma Treatment: The Role of QLS-111 in Intraocular Pressure (IOP) Managementhttps://reachmd.com/news/emerging-approaches-in-glaucoma-treatment-the-role-of-qls-111-in-intraocular-pressure-iop-management/2475299/Persistent challenges in intraocular pressure control and patient adherence have led to the development of novel agents. QLS-111, which modulates ATP-sensitive potassium channels—proteins that help regulate cellular activity by controlling po
- Revolutionizing Asthma and COPD Management with Dual-Action Inhalers and Triple Therapieshttps://reachmd.com/news/revolutionizing-asthma-and-copd-management-with-dual-action-inhalers-and-triple-therapies/2475297/Reliance on short-acting bronchodilators and systemic corticosteroids (e.g., oral) has left many patients with asthma and COPD vulnerable to frequent exacerbations and cumulative side effects—an urgent challenge now being reshaped by dual-act
- How Environmental Metal Exposure Is Shaping Heart Failure Risk: Insights for Cardiologistshttps://reachmd.com/news/how-environmental-metal-exposure-is-shaping-heart-failure-risk-insights-for-cardiologists/2475311/A recent Columbia University cohort analysis has highlighted the surprising influence of
- Integrating Innovative Pharmacologic Strategies for Managing Obesity and Diabeteshttps://reachmd.com/news/integrating-innovative-pharmacologic-strategies-for-managing-obesity-and-diabetes/2475302/Obesity and diabetes frequently converge in clinical practice, creating a cycle in which escalating weight drives insulin resistance and unstable blood sugar levels exacerbate metabolic complications, underscoring the urgent need for integrat
- Chemotherapy Resistance: A New Frontier in Personalized Oncologyhttps://reachmd.com/news/chemotherapy-resistance-a-new-frontier-in-personalized-oncology/2475307/Chemotherapy resistance remains an underrecognized obstacle in personalized oncology, as tumor heterogeneity and adaptive survival mechanisms frequently render standard regimens ineffective. Understanding tumor heterogeneity is crucial for pr